A growing body of evidence shows that CD4+CD25+Foxp3+Tregs play a positive role in alleviating sepsis-induced rapid onset inflammation and improving the outcome of ALI/ARDS through both TGF-β-dependent and independent pathways (20, 22, 42, 81, 87, 98, 155). Here, FOXP3 is linked to Sepsis.